
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145795510.1021/acsomega.7b01856ArticleFacile Route to the Synthesis of 1,3-Diazahetero-Cycle-Fused
[1,2-a]Quinoline Derivatives via Cascade Reactions Chen Liang Huang Rong Kong Ling-Bin Lin Jun *Yan Sheng-Jiao *Key Laboratory of Medicinal Chemistry
for Natural Resource (Yunnan University), Ministry of Education, School
of Chemical Science and Technology, Yunnan
University, Kunming 650091, P. R. China* E-mail: linjun@ynu.edu.cn. Phone and Fax: +86 87165031633 (J.L).* E-mail: yansj@ynu.edu.cn. Phone and Fax: +86 87165031633 (S.-J.Y).26 01 2018 31 01 2018 3 1 1126 1136 27 11 2017 12 01 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A one-step
protocol without transition-metal catalysts with simple
post-treatment for the synthesis of 1,3-diazaheterocycle-fused [1,2-a]quinoline derivatives via the cascade reaction of 2-fluorobenzaldehyde
(1) and heterocyclic ketene aminals (2)
was developed. In the one-step cascade reaction, C=C and C–N
bonds were constructed, and the targeted compound can be efficiently
obtained by filtering without column chromatography. This protocol
describes a valuable route to concisely and feasibly obtain 1,3-diazaheterocycle-fused
[1,2-a]quinoline derivatives. The synthetic methodology
is particularly attractive because of the following features: low-cost
solvent, mild temperature, atom economy, high yield, and potential
biological activity of the product.

document-id-old-9ao7b01856document-id-new-14ao-2017-01856cccc-price
==== Body
Introduction
One of the most important
aspects of modern chemical synthesis
is that it is necessary to develop methods with a low environmental
impact.1−4 The United States Environmental Protection Agency (EPA) defined
the “green chemistry” concept as “the design
of chemical products and processes that reduce or eliminate the use
or generation of hazardous substances”.5 In the green chemistry field, the ideal synthesis6,7 should
be a combination of a number of environmental, health, safety, and
economic factors. Among them, group-assisted purification8−10 chemistry allows the synthesis of organic compounds without using
traditional purification technologies, including column chromatography
and recrystallization. This technology makes more efforts to find
environmentally benign reagents and reactions so as to reduce the
waste generated from silica and solvents, particularly toxic solvents.

Quinolines is an important class of well-known heterocyclic scaffolds;
they are embedded in many biological systems and have interesting
applications in agriculture, materials, chemical industry, and medicine,
for instance, as antimalarial (Figure 1, quinine),11,12 anticancer (Figure 1, camptothecin),13 antibacterial,14,15 insecticide
(Figure 1, quinclorac),
and so forth.16−18 Consequently, various methods of synthesis of quinolines
have been reported.19−27 Among them, the transition-metal-catalyzed C–H bond or N–H
bond activation approaches have provided numerous strategies for the
synthesis of quinoline.28−32

Figure 1 Biological
activity of quinolines and the targeted compounds.

Heterocyclic ketene aminals (HKAs) have been widely
used as a type
of versatile building blocks to construct various fused heterocyclic
compounds including quinolones,33,34 isoquinolin-1-imine,35 indoles,36 indolin-2-ones,37,38 isocoumarins,39 pyridines,40−42 pyrroles, and so forth43−47 Many of these compounds have a wide variety of biological activities,
such as antitumor,48−51 herbicidal, pesticidal,52,53 antileishmanial,54 and antibacterial.55,56 Therefore, it is vital and urgent to develop a green synthetic methodology
with benign conditions and straight-forward post-treatment for the
synthesis of quinoline derivatives by construction of C=C and
C–N bonds through the one-step cascade reaction.

Here,
we describe a cascade strategy for the regioselective convergent
synthesis of a series of 1,3-diazaheterocycle-fused [1,2-a]quinoline derivatives (3–4). To the best of
our knowledge, the synthesis of the polycyclic[1,2-a]quinoline derivatives by the cascade reaction of 2-fluorobenzaldehyde 1 and HKAs 2 (Scheme 1) has not been reported to date.

Scheme 1 Strategy
for the Cascade Reaction Synthesis of [1,2-a]Quinolines 3 and 4
Results and Discussion
In this work, we developed a
one-pot protocol to synthesize a series
of polycyclic quinoline derivatives. To obtain the optimal reaction
conditions for the synthesis of 1,3-diazaheterocycle-fused [1,2-a]quinoline 3ad, the reaction of 2-fluoro-5-nitrobenzaldehyde
(1a) with HKA (2d) was chosen as the model
reaction. First, the reaction mixture of 1a with 2d was ground under catalyst-free and solvent-free conditions
at room temperature (Table 1, entry 1). Then, the reaction temperature reached the melting
point of 1a (mp 60 °C), (Table 1, entry 2), and the results showed that the
reaction can proceed nonselectively to yield many byproducts. The
solvent-free condition is a disadvantage to the reaction, and we cannot
obtain a pure product. Subsequently, by performing the reaction in
the stoichiometric amount of base, such as K2CO3, t-BuOK, Cs2CO3, Et3N, and piperidine in the aprotic solvent 1,4-dioxane at reflux (Table 1, entries 3–7),
the results revealed that piperidine was the optimal catalyst for
this selective synthesis of [1,2-a]quinoline 3ad with an excellent yield (91%) (Table 1, entry 7). Afterward, we screened several
aprotic solvents, including acetonitrile (CH3CN), tetrahydrofuran
(THF), N,N-dimethylformamide (DMF),
or the protonic solvents ethanol and water (Table 1, entries 8–12). The results indicated
that the most suitable solvent for this defluorinaton and cyclization
reaction was 1,4-dioxane. Next, we screened the temperature and found
that the optimal temperature was 60 °C. In the postprocessing
stage, after the reaction solution was cooled and filtered, we observed
the hydrofluoric acid salt of piperidine mixed in the products. Considering
the environmental hazards, we added CaCl2 to absorb the
hydrofluoric acid produced by the defluorination reaction with piperidine
as a catalyst. Unexpectedly, the product 3ad was obtained
with a 97% yield (Table 1, entries 14) when the time of reaction was shortened to 30 min.
Ultimately, the optimal reaction conditions for preparation of 3ad were 1,4-dioxane as the solvent, with piperidine and CaCl2 as promoters, at 60 °C for 30 min.

Table 1 Optimized Conditions for the Synthesis
of [1,2-a]Quinoline 3ada
entry	solvent	promoter	T (°C)	time (h)	yieldb (%)	
1	 	 	rt	0.5	n.r.	
2	 	 	60	0.5	trace	
3	1,4-dioxane	K2CO3	reflux	2	23	
4	1,4-dioxane	Cs2CO3	reflux	2	21	
5	1,4-dioxane	t-BuOK	reflux	2	19	
6	1,4-dioxane	Et3N	reflux	2	75	
7	1,4-dioxane	piperidine	reflux	2	91	
8	acetonitrile	piperidine	reflux	2	54	
9	THF	piperidine	reflux	3	68	
10	DMF	piperidine	110	2	40	
11	EtOH	piperidine	reflux	2	90	
12	H2O	piperidine	reflux	5	14	
13	1,4-dioxane	piperidine	60	2	92	
14	1,4-dioxane	piperidine/CaCl2	60	0.5	97	
a Reaction conditions: 1a (1.1 mmol), 2d (1.0 mmol), promoter (1.5 mmol), solvent
(15 mL).

b Isolated yield
based on HKA 2d. n.r. = no reaction.

With the optimized conditions at
hand, we explored the scope and
limitations of the reactions involving different 2-fluorobenzaldehydes
(1a–1c) with various HKAs (2a–2p) (Table 2, entries
1–44). For HKAs 2, the electron-withdrawing groups
(Cl or Br) on the aromatic ring could accelerate the reaction rate,
otherwise the electron-donating groups (CH3 or CH3O) were the opposite because of the influence of the substituting
groups on the electrophilicity of the α-C of HKAs 2 (Scheme 1). Unexpectedly,
the reaction rate showed that Cl > Br > H > F > CH3 > OCH3, which maybe attributed
to the intermolecular
hydrogen bonding of fluorineon HKAs (2a & 2h) with the diamino group of piperidine. Moreover, the size of the
diazaheterocycle of HKAs 2 showed that the five-membered
ring provided the highest yields, and then the six-membered and seven-membered
rings (e.g., Table 2, entries 2 vs 9 vs 15). Additionally, when the different groups
(R1 = NO2, CF3, and F) were introduced
into the C5 position of 2-fluorobenzaldehyde 1, the yields
of 3 decreased (e.g., Table 2, entries 4, 20 & 34) as the electron-withdrawing
ability of the substituent groups decreased (NO2 > CF3 > F). The starting material 2-fluorobenzaldehyde 1 bearing a moderately electron-withdrawing group (such as
F, 1c) had difficulty to react with HKAs 2, unless
the reaction was carried out under reflux conditions and CaCl2 was indispensable. We conjectured that, for 2-fluorobenzaldehyde 1, the strong electron-withdrawing substituent group at the
C5 position could facilitate the removal of the fluorine atom at the
C2 position. At the same time, this leads to the enhancement of the
electrophilicity of the formyl group at the C1 position, which benefits
the attack with keto-carbonyl at the α-C position of HKAs 2.

Table 2 Cascade Reaction Synthesis of [1,2-a]Quinoline Derivatives 3a
entry	1 (R1/R2/R3)	2 (n/Ar)	T (°C)	time
(h)	3	yieldb (%)	
1	1a (H/NO2/H)	2a (1/4-FC6H4)	60	0.5	3aa	94	
2	1a (H/NO2/H)	2b (1/4-ClC6H4)	60	0.5	3ab	98	
3	1a (H/NO2/H)	2c (1/4-BrC6H4)	60	0.5	3ac	97	
4	1a (H/NO2/H)	2d (1/C6H5)	60	0.5	3ad	97	
5	1a (H/NO2/H)	2e (1/4-MeC6H4)	60	0.5	3ae	95	
6	1a (H/NO2/H)	2f (1/4-MeOC6H4)	60	0.5	3af	93	
7	1a (H/NO2/H)	2g (1/thiophene-2-yl)	60	0.5	3ag	92	
8	1a (H/NO2/H)	2h (2/4-FC6H4)	60	0.5	3ah	94	
9	1a (H/NO2/H)	2i (2/4-ClC6H4)	60	0.5	3ai	96	
10	1a (H/NO2/H)	2j (2/4-BrC6H4)	60	0.5	3aj	95	
11	1a (H/NO2/H)	2k (2/C6H5)	60	0.5	3ak	96	
12	1a (H/NO2/H)	2l (2/4-MeC6H4)	60	0.5	3al	92	
13	1a (H/NO2/H)	2m (2/4-MeOC6H4)	60	0.5	3am	91	
14	1a (H/NO2/H)	2n (2/thiophene-2-yl)	60	0.5	3an	91	
15	1a (H/NO2/H)	2o (3/4-ClC6H4)	60	0.5	3ao	93	
16	1a (H/NO2/H)	2p (3/4-MeC6H4)	60	0.5	3ap	92	
17	1b (H/CF3/H)	2a (1/4-FC6H4)	75	1	3ba	95	
18	1b (H/CF3/H)	2b (1/4-ClC6H4)	75	1	3bb	97	
19	1b (H/CF3/H)	2c (1/4-BrC6H4)	75	1	3bc	97	
20	1b (H/CF3/H)	2d (1/C6H5)	75	1	3bd	95	
21	1b (H/CF3/H)	2e (1/4-MeC6H4)	75	1	3be	92	
22	1b (H/CF3/H)	2f (1/4-MeOC6H4)	75	1	3bf	92	
23	1b (H/CF3/H)	2g (1/thiophene-2-yl)	75	1	3bg	93	
24	1b (H/CF3/H)	2h (2/4-FC6H4)	75	1	3bh	94	
25	1b (H/CF3/H)	2i (2/4-ClC6H4)	75	1	3bi	96	
26	1b (H/CF3/H)	2j (2/4-BrC6H4)	75	1	3bj	95	
27	1b (H/CF3/H)	2k (2/C6H5)	75	1	3bk	95	
28	1b (H/CF3/H)	2l (2/4-MeC6H4)	75	1	3bl	94	
29	1b (H/CF3/H)	2m (2/4-MeOC6H4)	75	1	3bm	93	
30	1b (H/CF3/H)	2n (2/thiophene-2-yl)	75	1	3bn	92	
31	1c (F/F/F)	2a (1/4-FC6H4)	reflux	2	3ca	93	
32	1c (F/F/F)	2b (1/4-ClC6H4)	reflux	2	3cb	95	
33	1c (F/F/F)	2c (1/4-BrC6H4)	reflux	2	3cc	94	
34	1c (F/F/F)	2d (1/C6H5)	reflux	2	3cd	94	
35	1c (F/F/F)	2e (1/4-MeC6H4)	reflux	2	3ce	92	
36	1c (F/F/F)	2f (1/4-MeOC6H4)	reflux	2	3cf	93	
37	1c (F/F/F)	2g (1/thiophene-2-yl)	reflux	2	3cg	92	
38	1c (F/F/F)	2h (2/4-FC6H4)	reflux	2	3ch	92	
39	1c (F/F/F)	2i (2/4-ClC6H4)	reflux	2	3ci	95	
40	1c (F/F/F)	2j (2/4-BrC6H4)	reflux	2	3cj	95	
41	1c (F/F/F)	2k (2/C6H5)	reflux	2	3ck	94	
42	1c (F/F/F)	2l (2/4-MeC6H4)	reflux	2	3cl	92	
43	1c (F/F/F)	2m (2/4-MeOC6H4)	reflux	2	3cm	90	
44	1c (F/F/F)	2n (2/thiophene-2-yl)	reflux	2	3cn	91	
a Conditions: 1 (1.1
mmol) and 2 (1.0 mmol) were heated in the solvent 1,4-dioxane
(15 mL) with piperidine (1.5 mmol) and CaCl2 (0.5 mmol)
as catalysts.

b Isolated yield
based on HKAs 2.

Furthermore, when 2,3,4,5,6-pentafluorobenzaldehyde 1d reacted with the five-membered ring HKAs 2, we synthesized
a new product 4, which had the piperidine as the substituent
(Table 3, entries 1–4).
The possible reason is that the electron-withdrawing formyl group
at the C1 position of 1d makes the fluorine atom at the
C4 position to be easily replaced by piperidine. The reaction was
performed under reflux for 6 h, and that was more difficult than the
synthesis of compounds 4. Unfortunately, the six-membered
and seven-membered rings HKAs 2 could not react with 1d.

Table 3 Cascade Reaction Synthesis of [1,2-a]Quinoline Derivatives 4a,b
a Conditions: 1 (1.1
mmol) and 2 (1.0 mmol) were heated in the solvent 1,4-dioxane
(15 mL) with piperidine (1.5 mmol) and CaCl2 (0.5 mmol)
as catalysts.

b Isolated yield
based on HKAs 2.

The chemical structures of polycyclic quinoline derivatives 3 and 4 were fully characterized by Fourier transform
infrared (FTIR), proton nuclear magnetic resonance (1H
NMR), carbon-13 nuclear magnetic resonance (13C NMR), and
high-resolution mass spectroscopy (HRMS) spectral analysis. To further
verify the structure of the target products, 3bf was
selected as a representative compound and unequivocally confirmed
by X-ray diffraction analysis, as shown in Figure 2 (CCDC 1587141).

Figure 2 ORTEP diagram of 3bf; ellipsoids are drawn at the
30% probability level.

A proposed mechanism for synthesis of 1,3-diazaheterocycle-fused
[1,2-a]quinoline derivatives 3 by the
cascade reaction of 2-fluorobenzaldehyde 1 and HKAs 2 is presented in Scheme 2. First, HKAs 2, with a strong electron-withdrawing
keto-carbonyl at the α-position and two electron-donating diamino
groups on the diazaheterocycle, can serve as a nucleophilic component
to react with the electrophilic formyl group of 2-fluorobenzaldehyde 1 to form the intermediate 5 via an aza–ene
addition. Then, the intermediate 5 is converted into
intermediate 6 via aromatization and results in the formation
of one C=C bond. Thereafter, intramolecular nucleophilic substitution
of fluorine intermediate 6 produces the target products 3. The outcome of the cascade reaction is one C=C bond,
one C–N bond, and one diazaheterocycle-fused ring.

Scheme 2 Mechanism
Hypotheses for the Synthesis of Target Compounds 3
To testify this mechanism,
we perform the reaction in 1,4-dioxane
at 60 °C promoted by piperidine and CaCl2 for about
10 min, and the mixture was cooled to room temperature. Then, the
reaction mixture was injected in high-performance liquid chromatography–HRMS
system. The molecular ion peak appeared in high-resolution mass spectrometry
(HRMS (TOF ES+) m/z:
calcd for C18H15FN3O3 [M
+ H]+, 340.1092; found, 340.1089) (see the Supporting Information, which is the HRMS spectra
of compound 6). On the basis of the results, we believe
that the proposed mechanism is reasonable.

Conclusions
To
summarize, we developed a method for the efficient synthesis
of 1,3-diazaheterocycle-fused [1,2-a]quinoline derivatives
via one-step cyclization of 2-fluorobenzaldehyde 1 and
HKAs 2. This is a concise, rapid, and environmentally
friendly method to prepare [1,2-a]quinoline derivatives
without extra post-treatment. The reaction has some attractive features,
including simple and mild conditions, atom economy, and operational
simplicity. Moreover, these series of bicyclic[1,2-a]quinolines may possess potential biological activities for use in
medical treatment of diseases. Our future investigations will be aimed
at discovering in vitro biological activities of compounds 3 and 4.

Experimental Section
General Methods
All received reagents and solvents
were used without further purification unless otherwise stated. Melting
points were determined on an XT-4A melting point apparatus and were
uncorrected. NMR spectra were recorded on Bruker DRX300 (1H: 300 MHz, 13C: 75 MHz), Bruker DRX400 (1H:
400 MHz, 13C: 100 MHz), Bruker DRX500 (1H: 500
MHz, 13C: 125 MHz), and Bruker DRX600 (1H: 600
MHz, 13C: 150 MHz) instruments with DMSO-d6 and CDCl3 as the solvents. The chemical shifts
(δ) are expressed in parts per million relative to the residual
deuterated solvent signal, and coupling constants (J) are given in hertz. IR spectra were recorded on an FT-IR Thermo
Nicolet Avatar 360 instrument using KBr pellets. HRMS (electrospray
ionization) was performed on an Agilent LC/MSD TOF instrument.

All received reagents and solvents were used without further purification
unless otherwise stated. The materials (1a–d)
were purchased from Aldrich Corporation Limited. HKAs 2 were prepared according to a procedure described in the literature.39,40 The structure of HKAs 2 was confirmed by 1H NMR, 13C NMR, and HRMS spectra.

General Procedure for the
Synthesis of Compounds 3–4
A mixture
of 2-fluorobenzaldehyde 1 (1.1 mmol),
HKAs 2 (1.0 mmol), and piperidine (1.5 mmol) is mixed
by stirring at different temperatures (1a as starting
material, the temperature of the reaction was 60 °C; 1b was 75 °C; 1c and 1d at reflux) in
1,4-dioxane (15 mL). When the solution of the reaction was clear,
CaCl2 (0.5 mmol) was added. After completion of the reaction,
as indicated by thin-layer chromatography (CH2Cl2–EtOAc, 1:10 v/v), the mixture was cooled to room temperature
and filtered. The solid was then washed with a small amount of ethanol
(ca. 5 mL) and dissolved in CHCl3 (20 mL). Then, the organic
phase was washed with saturated salt water (25 mL) and NaHCO3 (25 mL), dried over anhydrous Na2SO4, concentrated,
and petroleum ether was added for recrystallization to obtain the
pure product 3 or 4.

4-(4′-Fluorophenyl)methanoneyl-7-nitro-1,2-dihydroimi-dazo[1,2-a]quinoline (3aa)
Yellow solid, mp
229–230 °C; IR (KBr): 3438, 1636, 1613, 1517, 1330, 1263,
1154, 853 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 3.88–3.95 (m, 2H,
CH2N), 4.01–4.08 (m, 2H, NCH2), 6.98 (d, J = 9.3 Hz, 1H,
ArH), 7.35 (t, J = 8.9 Hz, 2H, ArH), 7.80 (s, 1H, CH), 7.97–8.02
(m, 2H, ArH), 8.24–8.28 (m, 1H, ArH), 8.45 (d, J = 2.4 Hz, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.5, 53.5, 112.4, 115.8 (d, J = 21.8 Hz), 119.1, 124.9, 127.2, 129.4, 132.4, 132.6 (d, J = 9.8 Hz), 136.2, 139.5, 143.9, 152.8, 165.4 (d, J = 251.3 Hz), 190.9; HRMS (TOF ES+) m/z: calcd for C18H13FN3O3 [M + H], 338.0935; found, 338.0935.

4-(4′-Chlorophenyl)methanoneyl-7-nitro-1,2-dihydroimi-dazo[1,2-a]quinoline (3ab)
Yellow solid, mp
273–274 °C; IR (KBr): 2938, 1635, 1610, 1330, 1265, 1093,
871 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 3.92–3.95 (m, 2H,
CH2N), 4.02–4.05 (m, 2H, NCH2), 7.00 (d, J = 9.0 Hz, 1H,
ArH), 7.59 (d, J = 8.4 Hz, 2H, ArH), 7.84 (s, 1H, CH), 7.91 (d, J = 8.7 Hz, 2H, ArH), 8.26–8.29
(m, 1H, ArH), 8.48 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.5, 53.4, 112.5, 119.1,
125.1, 127.3, 128.8, 129.1, 131.4, 134.4, 136.8, 138.8, 139.6, 143.9,
152.8, 191.3; HRMS (TOF ES+) m/z: calcd for C18H13N3O3Cl [M + H], 354.0640; found, 354.0638.

4-(4′-Bromophenyl)methanoneyl-7-nitro-1,2-dihydroimi-dazo[1,2-a]quinoline (3ac)
Yellow solid, mp
281–282 °C; IR (KBr): 3439, 2938, 1636, 1613, 1325, 1264,
1091, 868 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 3.89–3.95 (m, 2H,
CH2N), 4.02–4.09 (m, 2H, NCH2), 7.01 (d, J = 9.0 Hz, 1H,
ArH), 7.74 (d, J = 8.7 Hz, 2H, ArH), 7.83 (d, J = 6.9 Hz, 2H, ArH), 7.84 (s, 1H, CH), 8.27–8.31
(m, 1H, ArH), 8.49 (d, J = 2.4 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.5, 53.5, 112.5, 119.1,
125.1, 127.3, 128.1, 129.1, 131.4, 131.8, 134.8, 136.7, 139.6, 144.0,
152.8, 191.6; HRMS (TOF ES+) m/z: calcd for C18H13N3O3Br [M + H], 398.0134; found, 398.0137.

4-(Phenyl)methanoneyl-7-nitro-1,2-dihydroimidazo[1,2-a]quinoline (3ad)
Yellow solid, mp
284–285 °C; IR (KBr): 3439, 2927, 1635, 1592, 1325, 1262,
1094, 729 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 3.90–3.96 (m, 2H,
CH2N), 4.03–4.09 (m, 2H, NCH2), 7.01 (d, J = 9.3 Hz, 1H,
ArH), 7.54 (t, J = 7.5 Hz, 2H, ArH), 7.69 (t, J = 7.4 Hz, 1H, ArH), 7.80 (s, 1H, CH), 7.91 (d, J = 7.5 Hz, ArH), 8.27–8.30 (m,
1H, ArH), 8.48 (d, J = 2.4 Hz, 1H,
ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 50.8, 58.8, 117.7, 124.4, 130.2, 132.4,
134.0, 134.8, 135.0, 139.2, 140.9, 141.1, 144.8, 149.2, 158.1, 197.7;
HRMS (TOF ES+) m/z: calcd
for C18H14N3O3 [M + H],
320.1029; found, 320.1029.

4-(p-Tolyl)methanoneyl-7-nitro-1,2-dihydroimidazo[1,2-a]quinoline (3ae)
Yellow solid, mp
283–284 °C; IR (KBr): 3439, 2935, 1657, 1635, 1610, 1517,
1325, 1288, 1264, 1090, 870 cm–1; 1H
NMR (300 MHz, DMSO-d6) (δ, ppm):
2.39 (s, 3H, CH3), 3.92–3.95 (m,
2H, CH2N), 4.02–4.05 (m, 2H, NCH2), 7.00 (d, J = 9.0 Hz, 1H,
ArH), 7.34 (d, J = 7.8 Hz, 2H, ArH), 7.75 (s, 1H, CH), 7.80 (d, J = 7.8 Hz, 2H, ArH), 8.27 (d, J = 8.7 Hz, 1H, ArH), 8.47 (s, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 21.2, 45.5, 53.5, 112.3, 119.1, 124.8, 127.0,
129.3, 129.7, 129.9, 133.1, 135.5, 139.5, 143.8, 144.6, 152.8, 191.9;
HRMS (TOF ES+) m/z: calcd
for C19H16N3O3 [M + H],
334.1186; found, 334.1186.

4-(4′-Methoxyphenyl)methanoneyl-7-nitro-1,2-dihydroi-midazo[1,2-a]quinoline (3af)
Yellow solid, mp
260–261 °C; IR (KBr): 1651, 1613, 1592, 1330, 1260, 1172,
585 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 3.85 (s, 3H, OCH3), 3.89–3.96 (m, 2H, CH2N), 4.03–4.09 (m, 2H, NCH2), 7.00
(d, J = 9.3 Hz, 1H, ArH), 7.05 (d, J = 8.7 Hz, 2H, ArH), 7.72 (s, 1H, CH), 7.88 (d, J = 8.7 Hz, 2H, ArH), 8.25–8.29 (m, 1H, ArH), 8.46
(d, J = 2.4 Hz, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm):
45.5, 53.5, 55.6, 112.3, 114.0, 119.2, 124.7, 126.9, 128.4, 130.1,
132.0, 135.0, 139.5, 143.7, 152.9, 163.8, 190.7; HRMS (TOF ES+) m/z: calcd for C19H16N3O4 [M + H], 350.1135; found,
350.1132.

4-(Thiophen-2′-yl)methanoneyl-7-nitro-1,2-dihydroimid-azo[1,2-a]quinoline (3ag)
Orange solid, mp
274–275 °C; IR (KBr): 3076, 2975, 1641, 1589, 1410, 1324,
1262, 1054, 742 cm–1; 1H NMR (300 MHz,
DMSO-d6) (δ, ppm): 3.97–4.00
(m, 2H, CH2N), 4.04–4.06 (m, 2H,
NCH2), 7.00 (d, J = 9.0
Hz, 1H, ArH), 7.25–7.28 (m, 1H, CH), 7.86 (s, 1H, CH), 7.89–7.90 (m, 1H, CH), 8.14–8.16 (m, 1H, CH), 8.26–8.30
(m, 1H, ArH), 8.48 (d, J = 2.4 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.6, 53.5, 112.4, 119.0,
125.0, 127.3, 129.0, 135.7, 136.6, 136.9, 139.5, 142.5, 143.9, 152.5,
184.1; HRMS (TOF ES+) m/z: calcd for C16H12N3O3S [M + H], 326.0593; found, 326.0595.

5-(4′-Fluorophenyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3ah)
Yellow solid, mp 224–225 °C; IR (KBr): 2934,
1634, 1596, 1508, 1327, 1277, 907, 585 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ,
ppm): 1.90–1.92 (m, 2H, CH2), 3.27–3.31
(m, 2H, CH2N), 3.97–3.99 (m, 2H,
NCH2), 7.30–7.42 (m, 3H, ArH), 7.63 (s, 1H, CH), 7.95–8.00
(m, 2H, ArH), 8.25–8.29 (m, 1H, ArH), 8.44 (d, J = 2.4 Hz, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.3, 42.9, 44.4, 112.4, 115.8 (d, J = 22.5 Hz), 119.5, 124.2, 125.8, 130.8, 132.2 (d, J = 9.8 Hz), 132.7, 136.2, 140.4, 145.1, 146.7, 165.2 (d, J = 250.5 Hz), 192.5; HRMS (TOF ES+) m/z: calcd for C19H15N3O3F [M + H], 352.1091; found, 352.1088.

5-(4′-Chlorophenyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3ai)
Yellow solid, mp 272–273 °C; IR (KBr): 2928,
1662, 1640, 1324, 1277, 1094, 899, 834 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ,
ppm): 1.86–1.90 (m, 2H, CH2), 3.25–3.28
(m, 2H, CH2N), 3.92–3.96 (m, 2H,
NCH2), 7.36 (d, J = 9.3
Hz, 1H, ArH), 7.59 (s, 1H, CH),
7.70 (d, J = 8.7 Hz, 2H, ArH), 7.89
(d, J = 8.4 Hz, 2H, ArH), 8.24–8.28
(m, 1H, ArH), 8.42 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.4, 43.1, 44.3, 112.1,
119.4, 124.2, 125.8, 128.8, 130.3, 130.9, 134.7, 136.7, 138.4, 140.2,
145.3, 146.5, 193.0; HRMS (TOF ES+) m/z: calcd for C19H15N3O3Cl [M + H], 368.0796; found, 368.0795.

5-(4′-Bromophenyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3aj)
Yellow solid, mp 264–265 °C; IR (KBr): 2966,
1653, 1613, 1326, 1273, 743 cm–1; 1H
NMR (300 MHz, DMSO-d6) (δ, ppm):
1.86–1.90 (m, 2H, CH2), 3.25–3.28
(m, 2H, CH2N), 3.92–3.96 (m, 2H,
NCH2), 7.36 (d, J = 9.3
Hz, 1H, ArH), 7.59 (s, 1H, CH),
7.70 (d, J = 8.7 Hz, 2H, ArH), 7.81
(d, J = 8.4 Hz, 2H, ArH), 8.24–8.28
(m, 1H, ArH), 8.42 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.4, 43.1, 44.3, 112.1,
119.5, 124.2, 125.8, 127.6, 130.3, 131.0, 131.8, 135.1, 136.7, 140.3,
145.3, 146.5, 193.2; HRMS (TOF ES+) m/z: calcd for C19H15N3O3Br [M + H], 412.0291; found, 412.0291.

5-(Phenyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3ak)
Yellow solid, mp 285–286 °C; IR (KBr): 2954,
2849, 1640,
1595, 1324, 1277, 1095, 904, 718 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm):
1.88 (m, 2H, CH2), 3.27 (m, 2H, CH2N), 3.95 (m, 2H, NCH2), 7.37 (d, J = 9.3 Hz, 1H, ArH), 7.51 (t, J = 7.5 Hz, 2H, ArH), 7.56 (s, 1H, CH), 7.64 (t, J = 7.1 Hz, 1H, ArH), 7.90 (d, J = 7.5 Hz, ArH), 8.27–8.25 (m, 1H, ArH), 8.42 (s, 1H, ArH); 13C NMR
(75 MHz, DMSO-d6) (δ, ppm): 19.4,
43.1, 44.3, 112.1, 119.5, 124.1, 125.6, 128.7, 129.1, 129.8, 133.6,
135.9, 137.2, 140.3, 145.2, 146.5, 194.0; HRMS (TOF ES+) m/z: calcd for C19H16N3O3 [M + H], 334.1186; found,
334.1186.

5-(p-Tolyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3al)
Yellow solid, mp 282–283 °C; IR (KBr): 2959,
1642, 1595, 1323, 1277, 1093, 904 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm):
1.86–1.89 (m, 2H, CH2), 2.37 (s,
3H, CH3), 3.26–3.29 (m, 2H, CH2N), 3.92–3.96 (m, 2H, NCH2), 7.30 (d, J = 8.1 Hz, 2H, ArH), 7.35 (d, J = 9.3 Hz, 1H, ArH), 7.51 (s, 1H, CH), 7.78 (d, J = 8.1 Hz, 2H, ArH), 8.22–8.26
(m, 1H, ArH), 8.40 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.4, 21.2, 43.1, 44.3, 112.0,
119.5, 124.0, 125.6, 129.2, 129.2, 129.5, 133.5, 137.4, 140.2, 144.1,
145.2, 146.4, 193.5; HRMS (TOF ES+) m/z: calcd for C20H18N3O3 [M + H], 348.1342; found, 348.1341.

5-(4′-Methoxyphenyl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3am)
Yellow solid, mp 221–222 °C; IR (KBr): 2934,
1641, 1595, 1328, 1277, 1162, 986 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm):
1.87–1.90 (m, 2H, CH2), 3.27–3.30
(m, 2H, CH2N), 2.83 (s, 3H, OCH3), 3.92–3.96 (m, 2H, NCH2), 7.02 (d, J = 8.7 Hz, 2H, ArH), 7.35 (d, J = 9.3 Hz, 1H, ArH), 7.49 (s, 1H, CH), 7.85 (d, J = 8.7 Hz, 2H, ArH), 8.22–8.26
(m, 1H, ArH), 8.40 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.4, 43.1, 44.3, 55.6, 112.0,
113.9, 119.6, 123.9, 125.5, 128.9, 129.2, 131.6, 137.5, 140.2, 145.2,
146.4, 163.4, 192.4; HRMS (TOF ES+) m/z: calcd for C20H18N3O4 [M + H], 364.1291; found, 364.1293.

5-(Thiophen-2′-yl)methanoneyl-8-nitro-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3an)
Yellow solid, mp 224–225 °C; IR (KBr): 2960,
1645, 1594, 1511, 1329, 1279, 1054, 737 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ,
ppm): 1.89–1.92 (m, 2H, CH2), 3.31–3.35
(m, 2H, CH2N), 3.92–3.96 (m, 2H,
NCH2), 7.20–7.23 (m, 1H, CH), 7.34 (d, J = 9.3 Hz, 1H, ArH), 7.58 (s, 1H, CH), 7.77–7.79
(m, 1H, CH), 8.05–8.07 (m, 1H, CH), 8.22–8.40 (m, 1H, ArH), 8.40 (d, J = 2.7 Hz, 1H, ArH); 13C NMR
(75 MHz, DMSO-d6) (δ, ppm): 19.4,
43.1, 44.4, 112.0, 119.4, 124.2, 125.8, 128.9, 129.7, 135.5, 135.8,
136.6, 140.2, 143.1, 145.3, 146.1, 186.1; HRMS (TOF ES+) m/z: calcd for C17H14N3O3S [M + H], 340.0750; found,
340.0752.

6-(4′-Chlorophenyl)methanoneyl-9-nitro-1,2,3,4-tetrahy-dro-[1,3]diazepino[1,2-a]quinoline (3ao)
Yellow solid, mp
232–233 °C; IR (KBr): 2930, 1657, 1626, 1597, 1340, 1285,
1087, 840 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 1.78 (m, 2H, CH2), 2.04–2.07 (m, 2H, CH2), 3.62–3.66 (m, 2H, CH2N), 4.11–4.15
(m, 2H, NCH2), 7.38 (d, J = 9.3 Hz, 1H, ArH), 7.56 (d, J = 8.7 Hz, 2H, ArH), 7.62 (s, 1H, CH), 7.90 (d, J = 8.4 Hz, 2H, ArH), 8.22–8.26 (m, 1H, ArH), 8.45 (d, J = 2.7 Hz, 1H, ArH); 13C NMR
(75 MHz, DMSO-d6) (δ, ppm): 23.6,
25.0, 47.2, 49.2, 112.8, 120.0, 124.1, 125.6, 128.8, 130.6, 130.8,
134.8, 137.0, 138.2, 140.1, 146.9, 148.5, 192.9; HRMS (TOF ES+) m/z: calcd for C20H17ClN3O3 [M + H], 382.0953; found,
382.0952.

6-(p-Tolyl)methanoneyl-9-nitro-1,2,3,4-tetrahydro-[1,3]diazepino[1,2-a]quinoline (3ap)
Yellow solid, mp
236–237 °C; IR (KBr): 1663, 1636, 1594, 1500, 1486, 1327,
1265, 1206, 1090, 861, 819 cm–1; 1H NMR
(300 MHz, DMSO-d6) (δ, ppm): 1.79
(m, 2H, CH2), 2.04–2.08 (m, 2H,
CH2), 3.63–3.66 (m, 2H, CH2N), 4.11–4.15 (m, 2H, NCH2), 7.31 (d, J = 8.1 Hz, 1H, ArH), 7.37 (d, J = 9.3 Hz, 2H, ArH), 7.54 (s, 1H, CH), 7.79 (d, J = 8.1 Hz, 2H, ArH), 8.21–8.25
(m, 1H, ArH), 8.43 (d, J = 2.7 Hz,
1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 21.2, 23.6, 25.1, 47.2, 49.2,
112.8, 120.2, 123.9, 125.3, 129.1, 129.2, 129.7, 133.5, 137.8, 140.0,
143.9, 146.8, 148.5, 193.5; HRMS (TOF ES+) m/z: calcd for C21H20N3O3 [M + H], 362.1499; found, 362.1500.

4-(4′-Fluorophenyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinoline (3ba)
Yellow solid, mp
198–199 °C; IR (KBr): 3438, 1663, 1636, 1599, 1386, 1336,
1207, 1155, 1115, 1077, 998, 859, 610 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ,
ppm): 3.85–3.93 (m, 2H, CH2N),
3.98–4.04 (m, 2H, NCH2), 7.01 (d, J = 8.7 Hz, 1H, ArH), 7.30–7.38
(m, 2H, ArH), 7.72 (s, 1H, CH),
7.72–7.76 (dd, J1 = 9.0 Hz, J2 = 1.8 Hz, 1H, ArH), 7.92
(d, J = 1.5 Hz, 1H, ArH), 7.94–8.01
(m, 2H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.3, 53.3, 112.5, 115.8
(d, J2 = 21.8 Hz), 119.3, 119.8–120.7
(m), 124.4 (d, J1 = 269.3 Hz), 126.4,
128.2, 129.0, 132.5 (d, J3 = 9.8 Hz),
136.3, 142.1, 153.2, 165.3 (d, J1 = 251.3
Hz), 191.2; HRMS (TOF ES+) m/z: calcd for C19H13N2OF4 [M + H], 361.0958; found, 361.0958.

4-(4′-Chlorophenyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinoline (3bb)
Yellow solid, mp
232–233 °C; IR (KBr): 3442, 1661, 1635, 1580, 1334, 1206,
1159, 1112, 1076, 997, 840, 519 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm):
3.87–3.91 (m, 2H, CH2N), 3.98–4.02
(m, 2H, NCH2), 7.02 (d, J = 8.6 Hz, 1H, ArH), 7.59 (d, J = 8.3 Hz, 2H, ArH), 7.75 (s, 1H, ArH), 7.76 (s, 1H, ArH), 7.90 (d, J = 8.5 Hz, 2H, ArH), 7.94 (s, 1H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 45.7, 53.7, 112.9, 119.6, 120.5 (d, J2 = 32.5 Hz), 124.8 (d, J1 = 270.0 Hz), 126.9, 128.8, 129.1, 129.2, 131.7, 135.1, 137.2, 139.1,
142.6, 153.6, 192.0; HRMS (TOF ES+) m/z: calcd for C19H13N2OF3Cl [M + H], 377.0663; found, 377.0664.

4-(4′-Bromophenyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinoline (3bc)
Yellow solid, mp
237–238 °C; IR (KBr): 1662, 1635, 1582, 1399, 1334, 1206,
1159, 1111, 1075, 996, 837, 765 cm–1; 1H NMR (400 MHz, DCCl3) (δ, ppm): 4.22–4.27
(t, J = 12.2 Hz, 2H, CH2N), 4.35–4.42 (t, J = 12.4 Hz, 2H, NCH2), 7.04 (d, J = 11.2 Hz, 1H,
ArH), 7.66 (s, 1H, CH), 7.82 (m,
2H, ArH), 7.85–7.88 (m, 2H, ArH), 8.02 (d, J = 10.0 Hz, 2H, ArH); 13C NMR (125 MHz, DCCl3) (δ, ppm):
45.8, 53.9, 111.9, 119.2, 122.5 (m), 125.3, 126.7, 128.6, 129.0, 129.2,
131.4, 131.9, 134.9, 138.1, 142.0, 154.0, 191.5; HRMS (TOF ES+) m/z: calcd for C19H13N2OF3Br [M + H], 421.0157; found,
421.0158.

4-(Phenyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydro-imidazo[1,2-a]quinoline (3bd)
Yellow solid, mp
212–213 °C; IR (KBr): 1666, 1635, 1578, 1387, 1333, 1204,
1160, 1117, 1073, 996, 817, 519 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm):
3.85–3.92 (m, 2H, CH2N), 3.98–4.05
(m, 2H, NCH2), 7.02 (d, J = 8.7 Hz, 1H, ArH), 7.51–7.56 (m, 2H, ArH), 7.67 (d, J = 7.2 Hz, 1H, ArH), 7.71 (s, 1H, CH), 7.73–7.76
(dd, J1 = 8.7 Hz, J2 = 1.5 Hz, 1H, ArH), 7.89 (s, 1H, ArH), 7.92 (d, J = 5.4 Hz, 2H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 45.3, 53.3, 112.5, 119.3, 120.0 (d, J = 32.3 Hz), 124.4 (d, J = 277.5 Hz),
126.3, 128.2, 128.7, 129.3, 129.5, 133.8, 135.8, 135.9, 142.1, 153.2,
192.6; HRMS (TOF ES+) m/z: calcd for C19H14N2OF3 [M + H], 343.1052; found, 343.1050.

4-(p-Tolyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydro-imidazo[1,2-a]quinoline (3be)
Yellow solid, mp
249–250 °C; IR (KBr): 1660, 1637, 1333, 1206, 1157, 1110,
1075, 997, 828, 762 cm–1; 1H NMR (300
MHz, DMSO-d6) (δ, ppm): 2.38 (s,
3H, CH3), 3.85–3.91 (m, 2H, CH2N), 3.97–4.04 (m, 2H, NCH2), 7.00 (d, J = 8.7 Hz, 1H, ArH), 7.32 (d, J = 8.7 Hz, 2H, ArH), 7.66 (s, 1H, CH), 7.73 (d, J = 8.4 Hz, 1H, ArH), 7.78 (d, J1 = 8.1 Hz, 2H, ArH), 7.92
(s, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 21.2, 45.3, 53.3, 112.4,
119.3, 119.7, 124.4 (d, J = 269.3 Hz), 126.2, 128.1,
129.3, 129.5, 129.6, 133.3, 135.5, 142.0, 144.4, 153.2, 192.1; HRMS
(TOF ES+) m/z: calcd
for C20H16N2OF3 [M + H],
357.1209; found, 357.1210.

4-(4′-Methoxyphenyl)methanoneyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinoline (3bf)
Yellow solid, mp
228–229 °C; IR (KBr): 2945, 1658, 1635, 1596, 1387, 1334,
1265, 1205, 1155, 1109, 856 cm–1; 1H
NMR (500 MHz, DMSO-d6) (δ, ppm):
3.85 (s, 3H, CH3), 3.88–3.92 (m,
2H, CH2N), 4.00–4.04 (m, 2H, NCH2), 7.03 (d, J = 9.0 Hz, 1H,
ArH), 7.05 (d, J = 8.6 Hz, 2H, ArH), 7.65 (s, 1H, CH), 7.75 (d, J = 8.5 Hz, 1H, ArH), 7.88 (d, J1 = 8.5 Hz, 2H, ArH), 7.92
(s, 1H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 45.7, 53.6, 56.0, 112.8,
114.4, 119.8, 120.2, 125.9, 126.5, 128.4, 129.0, 130.1, 132.4, 135.5,
142.3, 153.7, 164.2, 192.4; HRMS (TOF ES+) m/z: calcd for C20H16N2O2F3 [M + H], 373.1158; found, 373.1160.

4-(Thiophen-2′-yl)methanoneyl-7-(trifluoromethyl)-1,2-dihydroimidazo[1,2-a]quinoline (3bg)
Orange solid, mp
208–209 °C; IR (KBr): 3069, 1650, 1633, 1413, 1334, 1204,
1159, 1118, 1073, 821, 743 cm–1; 1H NMR
(500 MHz, DMSO-d6) (δ, ppm): 3.92–3.96
(m, 2H, CH2N), 4.00–4.04 (m, 2H,
NCH2), 7.00 (d, J = 8.7
Hz, 1H, CH), 7.26 (t, J = 4.3 Hz,
1H, CH), 7.73–7.75 (m, 1H, CH), 7.78 (s, 1H, CH), 7.88 (d, J = 3.7 Hz, 1H, ArH), 7.93 (s, 1H, ArH), 8.13 (d, J = 4.8 Hz, 1H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 45.8, 53.6, 56.0, 112.8, 119.6, 120.4 (d, J = 32.5 Hz), 124.8 (d, J = 270.0 Hz),
126.8, 128.7, 129.0, 129.3, 136.2, 136.6, 136.9, 142.4, 143.0, 153.4,
184.7; HRMS (TOF ES+) m/z: calcd for C17H12N2OF3S [M + H], 349.0616; found, 349.0614.

5-(4′-Fluorophenyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]-quinoline (3bh)
Yellowy solid, mp 172–173 °C; IR (KBr): 1668,
1642, 1596, 1319, 1210, 1154, 1116, 846, 814 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 1.87–1.89 (m, 2H, CH2), 3.25–3.27 (m, 2H, CH2N), 3.90–3.92 (m, 2H, NCH2), 7.32
(t, J = 8.6 Hz, 2H, ArH), 7.37 (d, J = 8.9 Hz, 1H, ArH), 7.49 (s, 1H, CH), 7.75 (d, J1 = 8.7 Hz, 1H,
ArH), 7.89 (s, 1H, ArH), 7.95–7.98
(m, 2H, ArH); 13C NMR (123 MHz, DMSO-d6) (δ, ppm): 19.9, 43.5, 44.3, 112.4,
116.1 (d, J = 22.5 Hz), 119.9, 121.3 (d, J = 33.8 Hz), 124.7 (d, J = 268.8 Hz),
126.1 (d, J = 3.8 Hz), 127.4 (d, J = 2.5 Hz), 130.4, 132.4 (d, J = 10.0 Hz), 133.3,
137.0, 143.8, 147.2, 165.5 (d, J = 252.5 Hz), 193.2;
HRMS (TOF ES+) m/z: calcd
for C20H15N2OF4 [M + H],
375.1115; found, 375.1113.

5-(4′-Chlorophenyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]-quinoline (3bi)
Yellowy solid, mp 181–182 °C; IR (KBr): 2931,
1670, 1640, 1592, 1319, 1208, 1161, 1115, 815 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 1.85–1.88 (m, 2H, CH2), 3.22–3.26 (m, 2H, CH2N), 3.89–3.92 (m, 2H, NCH2), 7.37
(d, J = 8.7 Hz, 1H, ArH), 7.51 (s,
1H, CH), 7.55 (d, J = 8.4 Hz, 2H,
ArH), 7.75 (d, J = 9.0 Hz, 1H, ArH), 7.87–7.90 (m, 3H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ,
ppm): 19.5, 43.0, 43.9, 112.1, 119.5, 121.0 (d, J = 33.0 Hz), 124.3 (d, J = 270.0 Hz), 125.8, 127.0,
128.8, 130.4, 130.8, 134.9, 136.2, 138.2, 143.4, 146.8, 193.2; HRMS
(TOF ES+) m/z: calcd
for C20H15N2OF3Cl [M +
H], 391.0819; found, 391.0816.

5-(4′-Bromophenyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]-quinoline (3bj)
Yellowy solid, mp 195–196 °C; IR (KBr): 2951,
1671, 1641, 1590, 1318, 1277, 1112, 814 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ,
ppm): 1.86 (m, 2H, CH2), 3.23 (m, 2H,
CH2N), 3.88–3.92 (m, 2H, NCH2), 7.37 (d, J = 9.0 Hz, 1H,
ArH), 7.51 (s, 1H, CH), 7.70 (d, J = 8.4 Hz, 2H, ArH), 7.76 (d, J = 9.3 Hz, 1H, ArH), 7.80 (d, J = 8.4 Hz, 2H, ArH), 7.90 (s, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.5, 43.0, 43.8, 112.1, 119.5, 120.5 (d, J2 = 32.3 Hz), 124.3 (d, J1 = 269.3 Hz), 125.8, 127.1, 127.5, 130.4, 130.9, 131.8, 135.2,
136.2, 143.4, 146.8, 193.5; HRMS (TOF ES+) m/z: calcd for C20H15N2OF3Br [M + H], 435.0314; found, 435.0317.

5-(Phenyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3bk)
Yellowy solid, mp 187–188 °C; IR (KBr): 1667,
1640, 1589, 1343, 1320, 1213, 1160, 1099, 814 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 1.87–1.89 (m, 2H, CH2), 3.24–3.26 (m, 2H, CH2N), 3.90–3.93 (m, 2H, NCH2), 7.37
(d, J = 8.9 Hz, 1H, ArH), 7.48–7.52
(m, 3H, CH), 7.63 (t, J = 7.4 Hz,
1H, ArH), 7.75 (d, J = 8.8 Hz, 1H,
ArH), 7.88–7.90 (m, 3H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 19.9, 43.4, 44.3, 112.4, 120.0, 121.4 (d, J = 32.5 Hz), 124.8 (d, J = 267.5 Hz),
126.0, 127.3, 129.0, 129.4, 130.3, 133.8, 136.5, 137.2, 143.7, 147.3,
194.6; HRMS (TOF ES+) m/z: calcd for C20H16N2OF3 [M + H], 357.1209; found, 357.1205.

5-(p-Tolyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3bl)
Yellowy solid, mp 226–227 °C; IR (KBr): 1663,
1642, 1319, 1209, 1160, 1112, 1083, 828 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ,
ppm): 1.86–1.88 (m, 2H, CH2), 2.37
(s, 3H, CH3), 3.24–3.26 (m, 2H,
CH2N), 3.89–3.92 (m, 2H, NCH2), 7.30 (d, J = 8.0 Hz, 2H,
ArH), 7.36 (d, J = 8.9 Hz, 1H, ArH), 7.43 (s, 1H, CH), 7.74 (d, J = 8.7 Hz, 1H, ArH), 7.78 (d, J = 8.1 Hz, 2H, ArH), 7.88 (s, 1H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 19.9, 21.6, 43.4, 44.3, 112.4, 120.0,
121.3 (d, J = 32.5 Hz), 124.8 (d, J = 270.0 Hz), 125.9, 127.1, 127.2, 129.6, 129.9, 134.1, 137.4, 143.7,
144.4, 147.2, 194.2; HRMS (TOF ES+) m/z: calcd for C21H18N2OF3 [M + H], 371.1365; found, 371.1363.

5-(4′-Methoxyphenyl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]-quinoline (3bm)
White solid, mp 192–193 °C; IR (KBr): 1662,
1641, 1593, 1319, 1264, 1157, 1029, 839 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ,
ppm): 1.87–1.88 (m, 2H, CH2), 3.26
(m, 2H, CH2N), 3.84 (s, 3H, CH3), 3.90–3.91 (m, 2H, NCH2), 7.01–7.03 (m, 2H, ArH), 7.36 (d, J = 8.8 Hz, 1H, ArH), 7.41 (s, 1H, CH), 7.74 (d, J = 8.8 Hz, 1H, ArH), 7.84–7.88 (m, 3H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ,
ppm): 19.9, 43.4, 44.3, 55.9, 112.3, 114.3, 120.0, 121.3 (d, J = 32.5), 124.8 (d, J = 270.0 Hz), 125.9,
127.2, 127.2, 129.5, 129.7, 137.5, 143.7, 147.2, 163.8, 193.1; HRMS
(TOF ES+) m/z: calcd
for C21H18N2O2F3 [M + H], 387.1314; found, 387.1317.

5-(Thiophen-2′-yl)methanoneyl-8-(trifluoromethyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3bn)
Light red solid, mp 209–210 °C; IR (KBr):
1645, 1586, 1343, 1319, 1209, 1156, 1102, 821, 732 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm): 1.87–1.91 (m, 2H, CH2), 3.29–3.32 (m, 2H, CH2N), 3.88–3.92 (m, 2H, NCH2), 7.19–7.22
(m, 1H, CH), 7.35 (d, J = 8.7 Hz,
1H, CH), 7.50 (s, 1H, CH), 7.72–7.76
(m, 2H, CH), 7.88 (d, J = 1.8 Hz,
1H, ArH), 8.04 (dd, J1 = 4.8 Hz, J2 = 1.2 Hz, 1H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.5, 43.0, 43.9, 112.0, 119.4, 120.9 (q, J2 = 32.3 Hz), 124.3 (d, J1 = 269.3 Hz), 125.7, 126.1, 127.0, 128.7, 129.8, 135.2, 135.5,
136.2, 143.3 (d, J3 = 9.8 Hz), 146.5,
186.3; HRMS (TOF ES+) m/z: calcd for C18H14N2OF3S [M + H], 363.0773; found, 363.0777.

6,7,9-Trifluoro-4-(4′-fluorophenyl)methanoneyl-1,2-dihy-droimidazo[1,2-a]quinoline (3ca)
Red solid, mp 177–178
°C; IR (KBr): 1668, 1636, 1598, 1496, 1393, 1267, 1157, 858,
603 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 3.84 (t, J = 10.3 Hz, 2H, CH2N), 4.20–4.25
(m, 2H, NCH2), 7.35 (t, J = 8.7 Hz, 2H, ArH), 7.61 (s, 1H, CH), 7.70–7.76 (m, 1H, ArH), 7.97–8.00
(m, 2H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 48.6, 54.1, 108.8 (t, J = 25.0 Hz), 111.5 (d, J = 15.0 Hz), 116.2
(d, J = 22.5 Hz), 126.4 (d, J =
13.8 Hz), 127.3, 131.2, 132.7, 132.9 (d, J = 10.0
Hz), 140.9 (t, J = 11.9 Hz), 141.9 (m), 142.7 (d, J = 12.5 Hz), 143.9 (t, J = 18.8 Hz), 153.7,
165.8 (d, J = 251.3 Hz), 191.1; 19F NMR
(565 MHz, DMSO-d6) (δ, ppm): −148.4
(t, J = 16.9 Hz), −147.0 (d, J = 22.6 Hz), −132.8 (d, J = 11.3 Hz), −104.5;
HRMS (TOF ES+) m/z: calcd
for C18H11N2OF4 [M + H],
347.0802; found, 347.0801.

6,7,9-Trifluoro-4-(4′-chlorophenyl)methanoneyl-1,2-dihy-droimidazo[1,2-a]quinoline (3cb)
Red solid, mp 186–187
°C; IR (KBr): 1664, 1638, 1595, 1499, 1393, 1269, 1090, 776 cm–1; 1H NMR (600 MHz, DMSO-d6) (δ, ppm): 3.81–3.85 (m, 2H, CH2N), 4.21–4.26 (m, 2H, NCH2), 7.60 (d, J = 8.5 Hz, 2H, ArH), 7.65 (s, 1H, CH), 7.73–7.78 (m, 1H, ArH), 7.91 (d, J = 8.5 Hz, 2H, ArH); 13C NMR (150 MHz, DMSO-d6) (δ, ppm): 48.7 (d, J = 9.0 Hz),
54.2, 109.0 (t, J = 25.5 Hz), 111.6 (d, J = 10.5 Hz), 126.6 (d, J = 10.0 Hz), 127.8, 129.3,
131.0, 131.8, 134.8, 139.4, 141.1, 142.5 (d, J =
60.0 Hz), 144.0 (d, J = 8.8 Hz), 153.8, 191.7; HRMS
(TOF ES+) m/z: calcd
for C18H11N2OF3Cl [M +
H], 363.0506; found, 363.0503.

6,7,9-Trifluoro-4-(4′-bromophenyl)methanoneyl-1,2-dihy-droimidazo[1,2-a]quinoline (3cc)
Orange solid, mp
203–204 °C; IR (KBr): 1663, 1635, 1586, 1496, 1269, 1124,
774, 609 cm–1; 1H NMR (600 MHz, DMSO-d6 + DCCl3) (δ, ppm): 3.83 (t, J = 10.3 Hz, 2H, CH2N), 4.21–4.26
(m, 2H, NCH2), 7.64 (s, 1H, CH), 7.73–7.74 (m, 3H, ArH), 7.82 (d, J = 8.4 Hz, 2H, ArH); 13C NMR
(150 MHz, DMSO-d6 + DCCl3)
(δ, ppm): 48.7 (d, J = 9.0 Hz), 54.2, 109.0
(t, J = 25.5 Hz), 111.6 (d, J =
10.5 Hz), 126.6, 127.9, 128.6, 131.0, 131.8, 132.3, 135.1, 141.1,
142.7, 143.9 (d, J = 51.0 Hz), 153.8, 191.8; HRMS
(TOF ES+) m/z: calcd
for C18H11N2OF3Br [M +
H], 407.0001; found, 407.0000.

6,7,9-Trifluoro-4-(phenyl)methanoneyl-1,2-dihydroimid-azo[1,2-a]quinoline (3cd)
Orange solid, mp
195–196 °C; IR (KBr): 1667, 1636, 1498, 1392, 1270, 803,
609 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 3.84 (t, J = 10.3 Hz, 2H, CH2N), 4.21–4.26
(m, 2H, NCH2), 7.54 (d, J = 7.7 Hz, 2H, ArH), 7.59 (s, 1H, CH), 7.67–7.76 (m, 2H, ArH), 7.90 (d, J = 7.5 Hz, 2H, ArH); 13C NMR
(125 MHz, DMSO-d6) (δ, ppm): 48.6
(d, J = 8.8 Hz), 54.1, 108.7 (t, J = 24.4 Hz), 111.5 (d, J = 11.3 Hz), 126.4 (d, J = 12.5 Hz), 127.1, 129.1, 129.8, 131.4, 134.3, 135.9,
140.9, 141.9, 142.8, 143.9 (d, J = 33.8 Hz), 153.7,
192.6; HRMS (TOF ES+) m/z: calcd for C18H12N2OF3 [M + H], 329.0896; found, 329.0894.

6,7,9-Trifluoro-4-(p-tolyl)methanoneyl-1,2-dihydroimid-azo[1,2-a]quinoline (3ce)
Red-orange solid,
mp 185–186 °C; IR (KBr): 1662, 1635, 1496, 1392, 1272,
1193, 603 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 2.39 (s, 3H, CH3), 3.83 (t, J = 10.3 Hz, 2H, CH2N), 4.19–4.25 (m, 2H, NCH2), 7.33 (d, J = 8.0 Hz, 2H, ArH), 7.53 (s, 1H, CH), 7.69–7.75
(m, 1H, ArH), 7.79 (d, J = 8.1 Hz,
2H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 21.6, 48.6 (d, J = 8.8 Hz), 54.1, 108.6 (t, J = 25.0 Hz), 111.6,
126.4, 126.7, 129.7, 130.0, 131.7, 133.5, 140.9, 141.9 (d, J = 30.0 Hz), 142.8, 143.9, 145.0, 153.7, 192.0; HRMS (TOF
ES+) m/z: calcd for C19H14N2OF3 [M + H], 343.1052;
found, 343.1050.

6,7,9-Trifluoro-4-(4′-methoxyphenyl)methanoneyl-1,2-di-hydroimidazo[1,2-a]quinoline (3cf)
Orange solid, mp
191–192 °C; IR (KBr): 1633, 1598, 1497, 1260, 1162, 1026,
603 cm–1; 1H NMR (300 MHz, DMSO-d6 + DCCl3) (δ, ppm): 3.82–3.89
(m, 2H, CH2N), 3.85 (s, 3H, CH3), 4.19–4.27 (m, 2H, NCH2), 7.02 (d, J = 9.0 Hz, 2H, ArH), 7.46 (d, J = 1.5 Hz, 1H, CH),
7.57–7.67 (m, 1H, ArH), 7.83–7.88 (m,
2H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 48.2 (d, J = 8.3 Hz), 5.71, 55.5, 108.0 (t, J = 24.8 Hz),
111.1 (d, J = 10.5 Hz), 113.9, 126.0, 128.3, 131.3,
131.9, 139.8, 140.8, 143.1 (d, J = 18.8 Hz), 144.0,
153.4, 163.8, 190.3; HRMS (TOF ES+) m/z: calcd for C19H14N2O2F3 [M + H], 359.1001; found, 359.0999.

6,7,9-Trifluoro-4-(thiophen-2-yl)methanoneyl-1,2-dihyd-roimidazo[1,2-a]quinoline (3cg)
Orange solid, mp
170–171 °C; IR (KBr): 1640, 1496, 1413, 1280, 1127, 733
cm–1; 1H NMR (600 MHz, DMSO-d6) (δ, ppm): 3.86–3.89 (m, 2H, CH2N), 4.22–4.25 (m, 2H, NCH2), 7.25–7.26 (m, 1H, CH), 7.63 (s,
1H, CH), 7.66–7.72 (m, 1H, ArH), 7.86–7.87 (m, 1H, CH), 8.13–8.14
(m, 1H, CH); 13C NMR (150 MHz, DMSO-d6) (δ, ppm): 48.8, 54.2, 108.9 (m), 111.5
(m), 126.5 (d, J = 12.0 Hz), 127.1, 129.4, 130.8,
136.9, 137.2, 141.1–142.7 (m), 142.0–142.4 (m), 142.9,
143.6–144.0 (m), 153.5, 184.4; HRMS (TOF ES+) m/z: calcd for C16H10N2OF3S [M + H], 335.0460; found, 335.0464.

7,8,10-Trifluoro-5-(4′-fluorophenyl)methanoneyl-2,3-di-hydro-1H-pyrimido[1,2-a]quinoline (3ch)
Yellow solid, mp 179–180 °C; IR (KBr): 2845,
1665, 1639, 1599, 1492, 1265, 1151, 992, 844 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm): 1.75 (m, 2H, CH2),
3.22 (m, 2H, CH2N), 4.14 (m, 2H, NCH2), 7.32 (t, J = 8.7 Hz, 2H,
ArH), 7.43 (s, 1H, CH), 7.66–7.72
(m, 1H, ArH), 7.94–7.97 (m, 2H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 20.1, 43.5, 48.5 (d, J = 17.5 Hz), 108.2 (m), 112.4 (d, J = 18.8 Hz),
116.0 (t, J = 25.6 Hz), 121.3, 127.4, 132.4 (d, J = 10.0 Hz), 133.2 (d, J = 10.0 Hz), 138.5,
141.5 (d, J = 21.3 Hz), 143.5 (d, J = 6.3 Hz), 145.6, 146.8, 165.5 (d, J = 251.3 Hz),
192.5; 19F NMR (470 MHz, DMSO-d6) (δ, ppm): −149.6, −145.5 (t, J = 9.4 Hz), −123.2, −105.3; HRMS (TOF ES+) m/z: calcd for C19H13N2OF4 [M + H], 361.0958; found,
361.0959.

7,8,10-Trifluoro-5-(4′-chlorophenyl)methanoneyl-2,3-di-hydro-1H-pyrimido[1,2-a]quinoline (3ci)
Yellow solid, mp 199–200 °C; IR (KBr): 2924,
1663, 1638, 1600, 1492, 1264, 1088, 991, 842 cm–1; 1H NMR (600 MHz, DMSO-d6 + HClO4) (δ, ppm): 2.16 (m, 2H, CH2), 3.54 (m, 2H, CH2N), 4.67
(m, 2H, NCH2), 7.71 (d, J = 8.2 Hz, 2H, ArH), 7.99 (d, J = 8.3 Hz, 2H, ArH), 8.26–8.31 (m, 1H, ArH), 8.48 (s, 1H, CH); 13C NMR
(150 MHz, DMSO-d6 + HClO4)
(δ, ppm): 18.3, 39.1, 50.8 (d, J = 19.5 Hz),
112.7 (m), 113.6 (d, J = 16.5 Hz), 124.8, 125.1,
129.6, 132.7, 134.9, 135.1, 140.3, 143.5 (d, J =
6.3 Hz), 145.6, 146.8, 150.7, 190.9; 19F NMR (565 MHz,
DMSO-d6 + HClO4) (δ,
ppm): −145.3 (m), −138.3 (m), −115.8; HRMS (TOF
ES+) m/z: calcd for C19H13N2OF3Cl [M + H], 377.0663;
found, 377.0665.

7,8,10-Trifluoro-5-(4′-bromophenyl)methanoneyl-2,3-di-hydro-1H-pyrimido[1,2-a]quinoline (3cj)
Yellow solid, mp 193–194 °C; IR (KBr): 2948,
1669, 1638, 1587, 1493, 1263, 1163, 1070, 906, 844 cm–1; 1H NMR (600 MHz, DMSO-d6) (δ, ppm): 1.74 (m, 2H, CH2),
3.21 (m, 2H, CH2N), 4.14 (m, 2H, NCH2), 7.47 (s, 1H, ArH), 7.71–7.72
(m, 3H, ArH), 7.79–7.81 (m, 2H, ArH); 13C NMR (150 MHz, DMSO-d6 + HClO4) (δ, ppm): 20.2, 43.6, 48.6
(d, J = 16.5 Hz), 108.4 (m), 112.5 (d, J = 18.0 Hz), 121.8, 127.5, 128.0, 131.5, 132.2, 135.6, 138.3, 141.9
(d, J = 12.0 Hz), 143.5, 144.0, 147.0, 193.3; HRMS
(TOF ES+) m/z: calcd
for C19H13N2OF3Br [M +
H], 421.0158; found, 421.0159.

7,8,10-Trifluoro-5-(phenyl)methanoneyl-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3ck)
Yellow solid, mp 191–192 °C; IR (KBr): 2958,
1669, 1638, 1597, 1492, 1267, 1198, 1165, 990, 665 cm–1; 1H NMR (600 MHz, DMSO-d6) (δ, ppm): 1.72–1.76 (m, 2H, CH2), 3.21 (m, 2H, CH2N), 4.13–4.16
(m, 2H, NCH2), 7.42 (s, 1H, CH), 7.48–7.52 (m, 2H, ArH), 7.64 (t, J = 7.4 Hz, 1H, ArH), 7.67–7.72
(m, 1H, ArH), 7.85–7.88 (m, 2H, ArH); 13C NMR (150 MHz, DMSO-d6) (δ, ppm): 20.2, 43.6, 48.6, 108.2 (m), 112.5
(t, J = 10.5 Hz), 121.2, 127.4, 129.1, 129.5, 134.0,
136.4, 138.9, 141.8 (m), 143.4 (m), 145.6 (m), 147.0, 194.0; HRMS
(TOF ES+) m/z: calcd
for C19H14N2OF3 [M + H],
343.1052; found, 343.1054.

7,8,10-Trifluoro-5-(p-tolyl)methanoneyl-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3cl)
Yellow solid, mp
196–197 °C; IR (KBr): 1663,
1602, 1492, 1268, 1163, 990, 836 cm–1; 1H NMR (300 MHz, DMSO-d6) (δ, ppm):
1.69–1.76 (m, 2H, CH2), 2.37 (s,
3H, CH3), 3.19–3.22 (m, 2H, CH2N), 4.10–4.16 (m, 2H, NCH2), 7.30 (d, J = 7.8 Hz, 2H, ArH), 7.35 (s, 1H, CH), 7.62–7.73
(m, 1H, ArH), 7.75 (d, J = 8.4 Hz,
2H, ArH); 13C NMR (75 MHz, DMSO-d6) (δ, ppm): 19.7, 21.2, 43.0, 48.2, 107.6
(m), 112.0 (d, J = 20.3 Hz), 120.4, 127.0, 129.2,
129.2, 133.5, 138.6, 140.6 (m), 143.7 (m), 142.6–145.8 (m),
144.0, 146.4, 193.1; HRMS (TOF ES+) m/z: calcd for C20H16N2OF3 [M + H], 357.1209; found, 357.1208.

7,8,10-Trifluoro-5-(4′-methoxyphenyl)methanoneyl-2,3-dihydro-1H-pyrimido[1,2-a]quinoline (3cm)
Yellow solid, mp 174–175 °C; IR (KBr): 1659,
1597, 1493, 1257, 1162, 1019, 849 cm–1; 1H NMR (500 MHz, DMSO-d6) (δ, ppm):
1.74–1.76 (m, 2H, CH2), 3.23–3.24
(m, 2H, CH2N), 3.85 (s, 3H, CH3), 4.14–4.15 (m, 2H, NCH2), 7.03 (d, J = 8.8 Hz, 2H, ArH), 7.34 (s, 1H, CH), 7.63–7.73 (m, 1H, ArH), 7.84 (d, J = 8.7 Hz, 2H, ArH); 13C NMR (125 MHz, DMSO-d6) (δ, ppm): 20.1, 43.4, 48.5, 56.0, 108.0 (m),
112.4, 114.3, 120.7, 127.3, 129.3, 131.9, 139.0, 141.6 (m), 143.3
(m), 143.7–145.5 (m), 146.8, 163.9, 192.3; HRMS (TOF ES+) m/z: calcd for C20H16N2O2F3 [M + H], 373.1158;
found, 373.1158.

7,8,10-Trifluoro-5-(thiophen-2′-yl)methanoneyl-2,3-dihy-dro-1H-pyrimido[1,2-a]quinoline (3cn)
Yellow solid, mp 178–179 °C; IR (KBr): 2959,
1641, 1599, 1492, 1409, 1256, 1197, 983, 857 cm–1; 1H NMR (600 MHz, DMSO-d6) (δ, ppm): 1.75–1.78 (m, 2H, CH2), 3.26–3.28 (m, 2H, CH2N), 4.12–4.15 (m, 2H, NCH2), 7.20–7.22
(m, 1H, CH), 7.42 (s, 1H, CH), 7.66–7.72
(m, 1H, ArH), 7.75–7.76 (m, 1H, CH), 8.04–8.05 (m, 1H, CH); 13C
NMR (150 MHz, DMSO-d6) (δ, ppm):
20.2, 43.5, 48.6, 108.4 (m), 112.3 (t, J = 7.5 Hz),
121.2, 127.5 (d, J = 7.5 Hz), 129.2, 135.8, 136.0,
138.3, 141.7–142.0 (m), 143.4–143.5 (m), 143.5, 143.8–145.5
(m), 146.6, 186.2; HRMS (TOF ES+) m/z: calcd for C17H12N2OF3S [M + H], 349.0616; found, 349.0618.

6,7,9-Trifluoro-4-(4′-fluorophenyl)methanoneyl-8-(piperi-din-1-yl)-1,2-dihydroimidazo-[1,2-a]quinoline (4da)
Red solid, mp 170–171
°C; IR (KBr): 2935, 2851, 1653, 1628, 1482, 1271, 1232, 1156,
1119, 1001, 848, 768, 602 cm–1; 1H NMR
(500 MHz, DMSO-d6 + CDCl3)
(δ, ppm): 1.62–1.68 (m, 6H, CH2), 3.23 (m, 4H, CH2), 3.84 (t, J = 10.2 Hz, 2H, CH2N), 4.21–4.26
(m, 2H, NCH2), 7.28 (t, J = 8.7 Hz, 2H, ArH), 7.48 (s, 1H, CH), 7.90–7.93 (m, 2H, ArH); 13C
NMR (125 MHz, DMSO-d6 + CDCl3) (δ, ppm): 24.0, 26.5, 48.8, 52.2, 53.9, 115.9 (d, J2 = 22.5 Hz), 127.3, 128.7, 132.7 (d, J3 = 10.0 Hz), 133.1, 133.6, 154.0, 165.7 (d, J1 = 252.5 Hz), 191.1; 19F NMR (471
MHz, DMSO-d6 + DCCl3) (δ,
ppm): −105.0, −145.9, −148.5, −156.9 (d, J = 18.8 Hz); HRMS (TOF ES+) m/z: calcd for C23H20N3OF4 [M + H], 430.1537; found, 430.1533.

6,7,9-Trifluoro-4-(4′-chlorophenyl)methanoneyl-8-(piperidin-1-yl)-1,2-dihydroimidazo-[1,2-a]quinoline (4db)
Red solid, mp 160–161
°C; IR (KBr): 2932, 2854, 1628, 1483, 1269, 1120, 1090, 1000,
844, 766 cm–1; 1H NMR (300 MHz, DMSO-d6 + CDCl3) (δ, ppm): 1.61 (m,
6H, CH2), 3.22 (m, 4H, CH2), 3.84 (t, J = 10.2 Hz, 2H, CH2N), 4.17–4.26 (m, 2H, NCH2), 7.47 (s, 1H, CH), 7.49 (d, J = 8.7 Hz, 2H, ArH), 7.82 (d, J = 8.4 Hz, 2H, ArH); 13C NMR
(75 MHz, DMSO-d6 + CDCl3) (δ,
ppm): 23.6, 26.1, 48.3, 51.8, 53.6, 103.2, 126.0, 126.5, 128.5, 128.8,
131.0, 134.7, 138.6, 153.6, 191.0; HRMS (TOF ES+) m/z: calcd for C23H20ClN3OF3 [M + H], 446.1242; found, 446.1239.

6,7,9-Trifluoro-4-(4′-bromophenyl)methanoneyl-8-(piperidin-1-yl)-1,2-dihydroimidazo-[1,2-a]quinoline (4dc)
Orange solid, mp
181–181 °C; IR (KBr): 2933, 2855, 1654, 1633, 1478, 1386,
1270, 1156, 1121, 997, 832, 761 cm–1; 1H NMR (500 MHz, DMSO-d6 + CDCl3) (δ, ppm): 1.62 (m, 6H, CH2),
3.24 (m, 4H, CH2), 3.83 (t, J = 10.2 Hz, 2H, CH2N), 4.21–4.26
(m, 2H, NCH2), 7.52 (s, 1H, CH), 7.69 (d, J = 8.4 Hz, 2H, ArH), 7.76 (d, J = 8.4 Hz, 2H, ArH); 13C NMR (150 MHz, DMSO-d6 + CDCl3) (δ, ppm): 23.80, 26.6, 44.7, 50.8, 52.4,
104.9, 114.7, 124.0, 126.6, 127.0, 128.1, 131.9, 132.4, 135.6, 137.4,
138.1, 139.7, 140.2, 140.5, 141.6, 146.7, 155.2, 190.9; 19F NMR (565 MHz, DMSO-d6 + DCCl3) (δ, ppm): −143.9, −144.0, −148.7 (d, J = 16.9 Hz); HRMS (TOF ES+) m/z: calcd for C23H20N3OF3Br [M + H], 490.0735; found, 490.0737.

6,7,9-Trifluoro-4-(phenyl)methanoneyl-8-(piperidin-1-yl)-1,2-dihydroimidazo[1,2-a]quinoline (4dd)
Orange-red solid,
mp 186–187 °C; IR (KBr): 2938, 2853, 1633, 1480, 1456,
1268, 1119, 1000, 656 cm–1; 1H NMR (600
MHz, DMSO-d6) (δ, ppm): 1.62 (m,
6H, CH2), 3.23 (m, 4H, CH2), 3.86 (t, J = 10.3 Hz, 2H, CH2N), 4.21–4.26 (m, 2H, NCH2), 7.43 (s, 1H, CH), 7.46–7.49
(m, 2H, ArH), 7.60–7.62 (m, 1H, ArH), 7.83 (d, J = 7.5 Hz, 2H, ArH); 13C NMR (150 MHz, DMSO-d6) (δ, ppm): 23.7, 26.5, 44.7, 50.7, 52.3, 104.8
(d, J3 = 19.5 Hz), 114.8, 124.0, 129.3,
129.9, 133.9, 136.5, 137.2, 137.9, 139.8, 140.4, 155.2, 191.7; 19F NMR (471 MHz, DMSO-d6 + DCCl3) (δ, ppm): −143.9, −144.6, −149.0
(d, J = 22.6 Hz); HRMS (TOF ES+) m/z: calcd for C23H21N3OF3 [M + H], 412.1631; found, 412.1633.

Supporting Information Available
The Supporting Information
is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b01856.Spectroscopic
and analytical data as well as the original
copy of 1H and 13C NMR spectra of all new compounds
and X-ray crystallographic data (CIF file) of compound 3bf (CCDC 1587141) (PDF)



Supplementary Material
ao7b01856_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
This work was supported
by the Program for Changjiang
Scholars and Innovative Research Team in University (no. IRT17R94),
the National Natural Science Foundation of China (nos. 21662042, 81760621,
21362042, U1202221), the Natural Science Foundation of Yunnan Province
(2017FA003), the Reserve Talent Foundation of Yunnan Province for
Middle-aged and Young Academic and Technical Leaders (no. 2012HB001),
Donglu Schloars of Yunnan University, Excellent Young Talents, Yunnan
University, and High-Level Talents Introduction Plan of Yunnan Province.
==== Refs
References
Agana B. A. ; Reeve D. ; Orbell J. D. 
An approach to industrial water conservation–a
case study involving two large manufacturing companies based in Australia . J. Environ. Manage. 
2013 , 114 , 445 –460 . 10.1016/j.jenvman.2012.10.047 .23182521 
Song Q.-W. ; Zhou Z.-H. ; He L.-N. 
Efficient,
selective and sustainable
catalysis of carbon dioxide . Green Chem. 
2017 , 19 , 3707 –3728 . 10.1039/c7gc00199a .
Marteel-Parrish A. E. 
Teaching
Green and Sustainable Chemistry: A Revised One-Semester Course Based
on Inspirations and Challenges . J. Chem. Educ. 
2014 , 91 , 1084 –1086 . 10.1021/ed400393b .
Singh J. ; Laurenti R. ; Sinha R. ; Frostell B. 
Progress and challenges
to the global waste management system . Waste
Manage. Res. 
2014 , 32 , 800 –812 . 10.1177/0734242x14537868 .
Chemat F. ; Vian M. A. ; Cravotto G. 
Green extraction
of natural products:
concept and principles . Int. J. Mol. Sci. 
2012 , 13 , 8615 –8627 . 10.3390/ijms13078615 .22942724 
Trost B. M. ; Osipov M. ; Dong G. 
Palladium-Catalyzed
Dynamic Kinetic
Asymmetric Transformations of Vinyl Aziridines with Nitrogen Heterocycles:
Rapid Access to Biologically Active Pyrroles and Indoles . J. Am. Chem. Soc. 
2010 , 132 , 15800 –15807 . 10.1021/ja1071509 .20949972 
Zhang W. ; Cue B. W. Jr. Green Techniques for Organic
Synthesis and Medicinal Chemistry , John Wiley & Sons, Ltd. , 2012 .
An G. ; Seifert C. ; Li G. 
N-Phosphonyl/phosphinyl imines and
group-assisted purification (GAP) chemistry/technology . Org. Biomol. Chem. 
2015 , 13 , 1600 –1617 . 10.1039/c4ob02254h .25523061 
Qiao S. ; Mo J. ; Wilcox C. B. ; Jiang B. ; Li G. 
Chiral GAP catalysts
of phosphonylated imidazolidinones and their applications in asymmetric
Diels–Alder and Friedel–Crafts reactions . Org. Biomol. Chem. 
2017 , 15 , 1718 –1724 . 10.1039/c6ob02801b .28139798 
Yu F.-C. ; Chen Z.-Q. ; Hao X.-P. ; Yan S.-J. ; Huang R. ; Lin J. 
Regioselective synthesis
of 9,10-dihydro-6H-chromeno[4,3-d]imidazo-[1,2-a]pyridin-6-one
derivatives . RSC Adv. 
2014 , 4 , 6110 –6115 . 10.1039/c3ra46428h .
Song C. E.  An Overview of Cinchona
Alkaloids in Chemistry ; Wiley-VCH Verlag
GmbH & Co. KGaA , 2009 ; pp 1 –10 .
Wootton J. C. ; Feng X. ; Ferdig M. T. ; Cooper R. A. ; Mu J. ; Baruch D. I. ; Magill A. J. ; Su X.-Z. 
Genetic diversity
and chloroquine selective sweeps in Plasmodium falciparum . Nature 
2002 , 418 , 320 –323 . 10.1038/nature00813 .12124623 
Murphy A. G. ; Casey R. ; Maguire A. ; Tosetto M. ; Butler C. T. ; Conroy E. ; Reynolds A. L. ; Sheahan K. ; O’Donoghue D. ; Gallagher W. M. ; Fennelly D. ; Kennedy B. N. ; O’Sullivan J. 
Preclinical
validation of the small molecule drug quininib as a novel therapeutic
for colorectal cancer . Sci. Rep. 
2016 , 6 , 34523 10.1038/srep34523 .27739445 
Dinakaran M. ; Senthilkumar P. ; Yogeeswari P. ; China A. ; Nagaraja V. ; Sriram D. 
Novel ofloxacin derivatives: synthesis, antimycobacterial
and toxicological evaluation . Bioorg. Med. Chem.
Lett. 
2008 , 18 , 1229 –1236 . 10.1016/j.bmcl.2007.11.110 .18068979 
Zhuang Z.-P. ; Kung M.-P. ; Wilson A. ; Lee C.-W. ; Plössl K. ; Hou C. ; Holtzman D. M. ; Kung H. F. 
Structure-Activity Relationship of
Imidazo[1,2-a]pyridines as Ligands for Detecting β-Amyloid Plaques
in the Brain . J. Med. Chem. 
2003 , 46 , 237 –243 . 10.1021/jm020351j .12519062 
Yang Y. ; Ang W. ; Long H. ; Chang Y. ; Li Z. ; Zhou L. ; Yang T. ; Deng Y. ; Luo Y. 
Scaffold Hopping Toward
Agomelatine: Novel 3,4-Dihydroisoquinoline Compounds as Potential
Antidepressant Agents . Sci. Rep. 
2016 , 6 , 34711 10.1038/srep34711 .27698414 
Meanwell N. A. 
2015 Philip
S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C
Virus Infection with Direct-Acting Antiviral Agents: The Arc of a
Medicinal Chemistry Triumph . J. Med. Chem. 
2016 , 59 , 7311 –7351 . 10.1021/acs.jmedchem.6b00915 .27501244 
Hu Y. ; Green N. ; Gavrin L. K. ; Janz K. ; Kaila N. ; Li H.-Q. ; Thomason J. R. ; Cuozzo J. W. ; Hall J. P. ; Hsu S. ; Nickerson-Nutter C. ; Telliez J.-B. ; Lin L.-L. ; Tam S. 
Inhibition of Tpl2
kinase and TNFalpha production with quinoline-3-carbonitriles
for the treatment of rheumatoid arthritis . Bioorg.
Med. Chem. Lett. 
2006 , 16 , 6067 –6072 . 10.1016/j.bmcl.2006.08.102 .16973359 
Zheng J. ; Li Z. ; Huang L. ; Wu W. ; Li J. ; Jiang H. 
Palladium-Catalyzed
Intermolecular Aerobic Annulation of o-Alkenylanilines and Alkynes
for Quinoline Synthesis . Org. Lett. 
2016 , 18 , 3514 –3517 . 10.1021/acs.orglett.6b01008 .27418021 
Yu X. ; Wang J. ; Xu Z. ; Yamamoto Y. ; Bao M. 
Copper-Catalyzed
Aza-Diels–Alder Reaction and Halogenation: An Approach To Synthesize
7-Halogenated Chromeno-quinolines . Org. Lett. 
2016 , 18 , 2491 –2494 . 10.1021/acs.orglett.6b01065 .27145113 
Neuhaus J. D. ; Morrow S. M. ; Brunavs M. ; Willis M. C. 
Diversely Substituted
Quinolines via Rhodium-Catalyzed Alkyne Hydroacylation . Org. Lett. 
2016 , 18 , 1562 –1565 . 10.1021/acs.orglett.6b00390 .26974467 
Min L. ; Pan B. ; Gu Y. 
Synthesis
of Quinoline-Fused 1-Benzazepines through
a Mannich-Type Reaction of a C,N-Bisnucleophile Generated from 2-Aminobenzaldehyde
and 2-Methylindole . Org. Lett. 
2016 , 18 , 364 –367 . 10.1021/acs.orglett.5b03287 .26757343 
Wakade S. B. ; Tiwari D. K. ; Prabhakar Ganesh P. S.
K. ; Phanindrudu M. ; Likhar P. R. ; Tiwari D. K. 
Transition-Metal-Free Quinoline Synthesis
from Acetophenones and Anthranils via Sequential One-Carbon Homologation/Conjugate
Addition/Annulation Cascade . Org. Lett. 
2017 , 19 , 4948 –4951 . 10.1021/acs.orglett.7b02429 .28880095 
Chi Y. ; Yan H. ; Zhang W.-X. ; Xi Z. 
Synthesis of Quinoline Derivatives
via Cu-Catalyzed Cascade Annulation of Heterocumulenes, Alkynes, and
Diaryliodonium Salts . Org. Lett. 
2017 , 19 , 2694 –2697 . 10.1021/acs.orglett.7b01025 .28481555 
Mao X.-F. ; Zhu X.-P. ; Li D.-Y. ; Liu P.-N. 
Cu-Catalyzed Cascade
Annulation of Alkynols with 2-Azidobenzaldehydes: Access to 6H-Isochromeno[4,3-c]quinoline . J. Org. Chem. 
2017 , 82 , 7032 –7039 . 10.1021/acs.joc.7b00937 .28553980 
Xu H. ; Zhou P. ; Zhou B. ; Zhou J. ; Shen Y. ; Lu L.-L. ; Yu F.-C. 
Convenient one-step synthesis of
pyrrolo[3,4-c]quinolin-1-ones via TMSCl-catalyzed cascade reactions
of isatins and β-enamino ketones . RSC
Adv. 
2016 , 6 , 73760 –73768 . 10.1039/c6ra15492a .
Xu H. ; Zhou B. ; Zhou P. ; Zhou J. ; Shen Y. ; Yu F.-C. ; Lu L.-L. 
Insights
into the unexpected chemoselectivity
in Bronsted acid catalyzed cyclization of isatins with enaminones:
convenient synthesis of pyrrolo[3,4-c]quinolin-1-ones and spirooxindoles . Chem. Commun. 
2016 , 52 , 8002 –8005 . 10.1039/c6cc02659a .
Midya S. P. ; Sahoo M. K. ; Landge V. G. ; Rajamohanan P. R. ; Balaraman E. 
Reversed reactivity of anilines with
alkynes in the
rhodium-catalysed C-H activation/carbonylation tandem . Nat. Commun. 
2015 , 6 , 8591 10.1038/ncomms9591 .26486182 
Manan R. S. ; Zhao P. 
Merging rhodium-catalysed
C-H activation and hydroamination in a
highly selective [4+2] imine/alkyne annulation . Nat. Commun. 
2016 , 7 , 11506 10.1038/ncomms11506 .27321650 
Heller S. T. ; Kiho T. ; Narayan A. R. H. ; Sarpong R. 
Protic-solvent-mediated
cycloisomerization of quinoline and isoquinoline propargylic alcohols:
syntheses of (+/-)-3-demethoxyerythratidinone and (+/-)-cocculidine . Angew. Chem., Int. Ed. 
2013 , 52 , 11129 –11133 . 10.1002/anie.201304687 .
Mastalir M. ; Glatz M. ; Pittenauer E. ; Allmaier G. ; Kirchner K. 
Sustainable
Synthesis of Quinolines and Pyrimidines Catalyzed by Manganese PNP
Pincer Complexes . J. Am. Chem. Soc. 
2016 , 138 , 15543 –15546 . 10.1021/jacs.6b10433 .27934004 
Jiang H. ; Cheng Y. ; Wang R. ; Zheng M. ; Zhang Y. ; Yu S. 
Synthesis of 6-alkylated phenanthridine
derivatives using photoredox
neutral somophilic isocyanide insertion . Angew.
Chem., Int. Ed. 
2013 , 52 , 13289 –13292 . 10.1002/anie.201308376 .
Yu F. ; Yan S. ; Hu L. ; Wang Y. ; Lin J. 
Cascade reaction of
isatins with heterocyclic ketene aminals: synthesis of imidazopyrroloquinoline
derivatives . Org. Lett. 
2011 , 13 , 4782 –4785 . 10.1021/ol201783d .21848302 
Zhang Y.-C. ; Liu Z.-C. ; Yang R. ; Zhang J.-H. ; Yan S.-J. ; Lin J. 
Regioselective construction of 1,3-diazaheterocycle fused [1,2-a][1,8]naphthyridine
derivatives via cascade reaction of quinolines with heterocyclic ketene
aminals: a joint experimental-computational approach . Org. Biomol. Chem. 
2013 , 11 , 7276 –7288 . 10.1039/c3ob41200h .24057033 
Yan S. ; Huang C. ; Su C. ; Ni Y. ; Lin J. 
Facile Route
to 1,3-Diazaheterocycle-Fused [1,2-b]Isoquinolin-1(2H)-one Derivatives
via Substitution-Cyclization Reactions . J. Comb.
Chem. 
2010 , 12 , 91 –94 . 10.1021/cc900121c .19911832 
Zhou B. ; Liu Z.-C. ; Qu W.-W. ; Yang R. ; Lin X.-R. ; Yan S.-J. ; Lin J. 
An environmentally
benign, mild,
and catalyst-free reaction of quinones with heterocyclic ketene aminals
in ethanol: site-selective synthesis of rarely fused [1,2-a]indolone
derivatives via an unexpected anti-Nenitzescu strategy . Green Chem. 
2014 , 16 , 4359 –4370 . 10.1039/c4gc00676c .
Yu F. ; Huang R. ; Ni H. ; Fan J. ; Yan S. ; Lin J. 
Three-component stereoselective synthesis
of spirooxindole derivatives . Green Chem. 
2013 , 15 , 453 –462 . 10.1039/c2gc36552a .
Chen X.-B. ; Liu X.-M. ; Huang R. ; Yan S.-J. ; Lin J. 
Three-Component
Synthesis of Indanone-Fused Spirooxindole Derivatives . Eur. J. Org. Chem. 
2013 , 21 , 4607 –4613 . 10.1002/ejoc.201300376 .
Yan S.-j. ; Chen Y.-j. ; Liu L. ; Tang Y.-j. ; Lin J. 
Synthesis
of novel tetracyclo-isocoumarins via AcOH-catalyzed cascade reaction
of heterocyclic ketene aminals with 2,2-dihydroxy-2H-indene-1,3-dione . Tetrahedron Lett. 
2011 , 52 , 465 –467 . 10.1016/j.tetlet.2010.11.100 .
Li M. ; Zhou Z.-M. ; Wen L.-R. ; Qiu Z.-X. 
Chemistry of Heterocyclic
Ketene Aminals: Construction of Imidazo(pyrido)[1,2-a]pyridines and
Imidazo(pyrido)[3,2,1-ij][1,8]naph-thyridines via DABCO-Catalyzed
Tandem Annulations . J. Org. Chem. 
2011 , 76 , 3054 –3063 . 10.1021/jo102167g .21449612 
Li M. ; Shao P. ; Wang S.-W. ; Kong W. ; Wen L.-R. 
Four-Component
Cascade Heteroannulation of Heterocyclic Ketene Aminals: Synthesis
of Functionalized Tetrahydroimidazo[1,2-a ]pyridine Derivatives . J. Org. Chem. 
2012 , 77 , 8956 –8967 . 10.1021/jo3013836 .22970749 
Chen L. ; Huang R. ; Du X.-X. ; Yan S.-J. ; Lin J. 
One-Pot Synthesis
of Highly Functionalized Bicyclic Imidazopyridinium Derivatives in
Ethanol . ACS Sustainable Chem. Eng. 
2017 , 5 , 1899 –1905 . 10.1021/acssuschemeng.6b02622 .
Zeng C.-C. ; Liu F.-J. ; Ping D.-W. ; Hu L.-M. ; Cai Y.-L. ; Zhong R.-G. 
One-Pot Electrochemical
Synthesis of Fused Indole Derivatives
Containing Active Hydroxyl Groups in Aqueous Medium . J. Org. Chem. 
2009 , 74 , 6386 –6389 . 10.1021/jo901091s .19575534 
Yaqub M. ; Arif N. ; Perveen R. ; Batool J. ; Riaz M. T. ; Yaseen M. 
One-pot three component
cascade synthesis of fused
ring quinazoline-2,4-dione derivatives employing heterocyclic ketene
aminals as a versatile synthone . Asian J. Chem. 
2015 , 27 , 1013 –1018 . 10.14233/ajchem.2015.18004 .
Chen X.-B. ; Liu Z.-C. ; Lin X.-R. ; Huang R. ; Yan S.-J. ; Lin J. 
Highly Diastereoselective
Convergent Synthesis of Polycyclic Pyrroles
with Consecutive Quaternary Stereocenters: Cascade Construction of
Multiple C-C and C-Hetero Bonds . ACS Sustainable
Chem. Eng. 
2014 , 2 , 2391 –2398 . 10.1021/sc5004105 .
Ma Y.-L. ; Wang K.-M. ; Huang R. ; Lin J. ; Yan S.-J. 
An environmentally
benign double Michael addition reaction of heterocyclic ketene aminals
with quinone monoketals for diastereoselective synthesis of highly
functionalized morphan derivatives in water . Green Chem. 
2017 , 19 , 3574 –3584 . 10.1039/c7gc01435j .
Chen X.-B. ; Liu Z.-C. ; Yang L.-F. ; Yan S.-J. ; Lin J. 
A Three-Component
Catalyst-Free Approach to Regioselective Synthesis of Dual Highly
Functionalized Fused Pyrrole Derivatives in Water–Ethanol Media:
Thermodynamics versus Kinetics . ACS Sustainable
Chem. Eng. 
2014 , 2 , 1155 –1163 . 10.1021/sc500170d .
Yan S.-J. ; Liu Y.-J. ; Chen Y.-L. ; Liu L. ; Lin J. 
An efficient
one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives
as anti-cancer agents . Bioorg. Med. Chem. Lett. 
2010 , 20 , 5225 –5228 . 10.1016/j.bmcl.2010.06.141 .20655212 
Huang C. ; Yan S.-J. ; Zeng X.-H. ; Dai X.-Y. ; Zhang Y. ; Qing C. ; Lin J. 
Biological
evaluation of polyhalo
1,3-diazaheterocycle fused isoquinolin-1(2H)-imine derivatives Eur . J. Med. Chem. 
2011 , 46 , 1172 –1180 . 10.1016/j.ejmech.2011.01.036 .
Yu F.-C. ; Lin X.-R. ; Liu Z.-C. ; Zhang J.-H. ; Liu F.-F. ; Wu W. ; Ma Y.-L. ; Qu W.-W. ; Yan S.-J. ; Lin J. 
Beyond the
Antagonism: Self-Labeled Xanthone Inhibitors as Modeled “Two-in-One”
Drugs in Cancer Therapy . ACS Omega 
2017 , 2 , 873 –889 . 10.1021/acsomega.6b00545 .30023617 
Du X.-X. ; Huang R. ; Yang C.-L. ; Lin J. ; Yan S.-J. 
Synthesis
and evaluation of the antitumor activity of highly functionalised
pyridin-2-ones and pyrimidin-4-ones . RSC Adv. 
2017 , 7 , 40067 –40073 . 10.1039/c7ra06466g .
Chen N. ; Meng X. ; Zhu F. ; Cheng J. ; Shao X. ; Li Z. 
Tetrahydroindeno [1′,2′:4,5]pyrrolo[1,2-a]imidazole-5(1H)-ones
as Novel Neonicotinoid Insecticides: Reaction Selectivity and Substituent
Effects on the Activity Level . J. Agric. Food
Chem. 
2015 , 63 , 1360 –1369 . 10.1021/jf505281p .25611859 
Bao H. ; Shao X. ; Zhang Y. ; Deng Y. ; Xu X. ; Liu Z. ; Li Z. 
Specific Synergist
for Neonicotinoid Insecticides:
IPPA08, a cis-Neonicotinoid Compound with a Unique Oxabridged Substructure . J. Agric. Food Chem. 
2016 , 64 , 5148 –5155 . 10.1021/acs.jafc.6b01512 .27281691 
Suryawanshi S. N. ; Pandey S. ; Rashmirathi ; Bhatt B. A. ; Gupta S. 
Chemotherapy of leishmaniasis
Part VI: Synthesis and bioevaluation of some novel terpenyl S,N- and
N,N-acetals . Eur. J. Med. Chem. 
2007 , 42 , 511 –516 . 10.1016/j.ejmech.2006.09.016 .17178176 
Kondo H. ; Taguchi M. ; Inoue Y. ; Sakamoto F. ; Tsukamoto G. 
Synthesis
and antibacterial activity of thiazolo-, oxazolo-, and imidazolo[3,2-a][1,8]naphthyri-dinecarboxylic
acids . J. Med. Chem. 
1990 , 33 , 2012 –2015 . 10.1021/jm00169a033 .2163456 
Abdelhalim M. M. ; El-Saidi M. M. T. ; Rabie S. T. ; Elmegeed G. A. 
Synthesis of novel
steroidal heterocyclic derivatives as antibacterial agents . Steroids 
2007 , 72 , 459 –465 . 10.1016/j.steroids.2007.01.003 .17386937

